Skip to content
+49 3371 6199600info@celltrend.deIm Biotechnologiepark 3 TGZ II, 14943 Luckenwalde
  • Contact
  • German
  • English
topbar - English
Search:
Suche
CellTrend Luckenwalde
Auftragsforschung, Antikörperdiagnostik
CellTrend LuckenwaldeCellTrend Luckenwalde
  • Company Profile
    • Newsroom
    • Board of management
    • Quality Management System
    • Referenzen
    • Partners
  • POTS–CFS/ME–SFN-Long Covid
    • Information for patients
  • ELISA
    • AT1R-Antibody ELISA
      • Product information
      • Transplantation
      • Systemic sclerosis
      • Literature
    • GPCR-Antibodies
    • In vitro Diagnostics (human)
    • Research use only
    • Food analysis
    • Contract research
    • Contract manufacturing
  • Consulting
  • Fluorescent Cells
  • Cell culture test systems
    • Oncology
    • Inflammatory test systems
    • Contract research
  • Ordering ELISA Kits
  • Company Profile
    • Newsroom
    • Board of management
    • Quality Management System
    • Referenzen
    • Partners
  • POTS–CFS/ME–SFN-Long Covid
    • Information for patients
  • ELISA
    • AT1R-Antibody ELISA
      • Product information
      • Transplantation
      • Systemic sclerosis
      • Literature
    • GPCR-Antibodies
    • In vitro Diagnostics (human)
    • Research use only
    • Food analysis
    • Contract research
    • Contract manufacturing
  • Consulting
  • Fluorescent Cells
  • Cell culture test systems
    • Oncology
    • Inflammatory test systems
    • Contract research
  • Ordering ELISA Kits

Daily Archives: 6. December 2018

You are here:
  1. Home
  2. 2018
  3. December
  4. 06

CellTrend has received the patent for auto-antibodies against VEGF

NewsBy celltrend celltrend6. December 2018

Vascular endothelial growth factor (VEGF) plays a central role in tumor growth, metastasis and angiogenesis. Various drugs (such as Avastin (R)) interfere tumor growth at this pathway. CellTrend were the first to describe auto-antibodies against VEGF and measures them with an validated ELISA. This discovery enables new strategies for personalization of tumor therapy and may…

+49 3371 6199600 info@celltrend.de Im Biotechnologiepark 3 TGZ II, 14943 Luckenwalde
  • Data protection declaration
  • Imprint
bottombar - English

FacebookInstagram

Go to Top
Um unsere Webseite für Sie optimal zu gestalten und fortlaufend zu verbessern, verwenden wir Cookies. Durch die weitere Nutzung der Webseite stimmen Sie deren Verwendung zu. Weitere Informationen erhalten Sie in unserer DatenschutzerklärungOK